Clinical Trials Logo

Bruxism clinical trials

View clinical trials related to Bruxism.

Filter by:

NCT ID: NCT05751694 Recruiting - Clinical trials for Gastroesophageal Reflux

Effectiveness of Visceral Manual Therapy in Bruxist Patients With Gastroesophageal Reflux

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Objective: check the effectiveness of visceral manual therapy on bruxist patients with gastroesophageal reflux. Design: Experimental, analytical, longitudinal, prospective, randomized, single-blind study with a blinded evaluator. Subjects: 68 subjects over 18 years old, with bruxism (diagnoses by a dentist) and gastroesophageal reflux (evidenced by the GERDQ test). Methods: Subjects will be randomized into 2 groups: an experimental group (EG) to which a visceral manual technique will be applied and a control group (CG) to which a placebo manual technique will be administered. Both groups will receive 2 interventions one week apart. The measurements will be made before and after the interventions, and a last measurement will be made one month after the last intervention. Therefore, the patient will visit the center 3 times.

NCT ID: NCT05657353 Completed - Bruxism Clinical Trials

Relation Between Bruxism and Cervical Function

Start date: December 8, 2022
Phase:
Study type: Observational

correlation between Bruxism and Cervical function

NCT ID: NCT05620316 Completed - Nocturnal Bruxism Clinical Trials

The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

Botulinum toxin (BOTOX®) injections into the masseter muscle are an effective treatment for nocturnal bruxism, with several trials using various dosages of botulinum toxin for this purpose. The aim was to evaluate the effectiveness of injecting 10MU of botulinum toxin A (BTXA) into the masseter muscle to reduce nocturnal bruxism, the sample will randomly divided into 2 groups. In the injection group, Patients will inject with 10 MU of botulinum toxin type A (BOTOX® - Allergan Inc. - Dublin - Ireland) per side at two sites into the masseter muscle bilaterally. In this Placebo group, patients will prick twice at the inferior prominent part of the masseter muscle observed using the stinger pen used in the blood glucose meter. The evaluation will make by Electromyography (EMG) analysis, Visual Analogue Scale (VAS) values.

NCT ID: NCT05604729 Recruiting - Bruxism Clinical Trials

The Effect on Envelope of Motion in Asymptomatic Bruxers

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Investigating the effect of botulinum neurotoxin on the jaw-neck envelope of motion.

NCT ID: NCT05594511 Recruiting - Clinical trials for Temporomandibular Joint Disorders

Mandibular Muscle Energy Technique in Patients With Mandibular Joint Pathology and Bruxism

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, double-blind clinical trial. The main objective is to evaluate the immediate effect of the mandibular muscle-energy technique on pain, functionality and kinesiophobia in subjects suffering from temporomandibular dysfunction and bruxism. In the experimental group the jaw muscle-energy technique will be applied and in the control group a placebo technique will be applied. The intention is to see the immediate effects of the intervention and two evaluations of the pre- and post-intervention outcome variables and a follow-up of kinesiophobia one week later will be performed.

NCT ID: NCT05562635 Recruiting - Clinical trials for Temporomandibular Disorder

CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

Start date: July 18, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the project is to assess the effectiveness of reducing the masseter muscles tension and hyperactivity in patients with a painful form of TMD by using polymers containing CBD compared to placebo polymers.

NCT ID: NCT05562531 Recruiting - Clinical trials for Temporomandibular Disorder

Botulinum Toxin Administration on Masticatory Performance

Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study aimed to evaluate the effect of botulinum toxin type A (BTX-A) injection on masticatory performance and nutritional status in temporomandibular disorder patients with bruxism caused by both intra-articular and extra-articular pathologies based on Research Diagnostic Criteria for temporomandibular disorders (TMD). The baseline and end masticatory performance, pain intensity, nutrition and anxiety statuses, and anthropometric measurements will be compared.

NCT ID: NCT05555628 Recruiting - Bruxism Clinical Trials

Comparison of Two Exercise Therapy Protocols in Patients With Bruxism

Start date: July 15, 2022
Phase: N/A
Study type: Interventional

The main purpose of this planned research is to investigate the effectiveness of three different methods used for the treatment of bruxism. Two of these are physiotherapy-specific exercise treatment protocols (1.posture and proprioception exercises 2. Jaw area strengthening exercises) and a control group, (occlusal splint therapy) will take place during the study.

NCT ID: NCT05416788 Completed - Bruxism Clinical Trials

Effect of Cervical Manipulation on Mouth Opening

Start date: May 11, 2022
Phase: N/A
Study type: Interventional

Objectives: To compare the effects of cervical manipulation on the ranges of motion of mouth opening and painful pressure points in the masseter and temporal muscles after of cervical manipulation compared to the control group. Material and methods: Single-blind randomized clinical trial with two arms, one group intervention and a control group. Hypothesis: There is a significant difference in mouth opening and painful pressure points between the intervention group and the control group. Expected results: The intervention group would significantly increase their mouth opening maximal and decrease pressure pain in the masseter and temporalis muscles.

NCT ID: NCT05352438 Completed - Clinical trials for Temporomandibular Disorder

Manual Therapy and Splint Therapy in Patients With Temporomandibular Dysfunction

Start date: January 21, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to compare the efficacy of splint treatment and manual therapy in patients diagnosed with myofascial temporomandibular dysfunction with bruxism.